IDEXX Laboratories Inc.

NASDAQ: IDXX · Real-Time Price · USD
651.27
-2.68 (-0.41%)
At close: Aug 15, 2025, 3:59 PM
650.82
-0.07%
After-hours: Aug 15, 2025, 06:03 PM EDT

IDEXX Laboratories Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
4.04B 3.93B 3.9B 3.84B 3.78B 3.72B 3.66B 3.59B 3.51B 3.43B 3.37B 3.34B 3.31B 3.27B 3.22B 3.14B 3.05B 2.86B
Cost of Revenue
1.55B 1.52B 1.52B 1.51B 1.5B 1.48B 1.47B 1.44B 1.41B 1.38B 1.36B 1.36B 1.37B 1.36B 1.33B 1.29B 1.25B 1.18B
Gross Profit
2.48B 2.41B 2.38B 2.34B 2.29B 2.24B 2.19B 2.15B 2.11B 2.05B 2B 1.98B 1.94B 1.92B 1.89B 1.84B 1.79B 1.68B
Operating Income
1.26B 1.15B 1.13B 1.11B 1.08B 1.12B 1.1B 1.08B 1.05B 930.82M 898.76M 871.43M 852.56M 932.75M 932.03M 917.93M 863.83M 797.82M
Interest Income
6.76M 9.48M 12.7M 14.13M 12.67M 9.64M 5.63M 2.23M 1.33M 1.34M 1.06M 999K 768K 525K 434K 434K 520K 498K
Pretax Income
1.23B 1.12B 1.11B 1.09B 1.06B 1.09B 1.06B 1.03B 1B 886.17M 859.97M 838.64M 823.41M 904.05M 902.65M 888.21M 833.21M 765.3M
Net Income
985.66M 894.97M 887.87M 866.24M 845.63M 866.57M 845.04M 822.73M 791.43M 699.18M 679.09M 669.65M 663.95M 734.55M 744.85M 756.86M 727.85M 674.21M
Selling & General & Admin
996.99M 1.04B 1.03B 1.01B 995.17M 925.46M 901.89M 887.82M 876.87M 858.42M 850.75M 847.7M 840.44M 821.05M 796.39M 770.1M 776.8M 738.89M
Research & Development
232.67M 226.22M 219.79M 213.88M 207.86M 198.92M 190.95M 182.56M 182.6M 259.32M 254.82M 256.71M 249.12M 163.6M 161.01M 154.48M 151.57M 145.52M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.23B 1.26B 1.25B 1.22B 1.2B 1.12B 1.09B 1.07B 1.06B 1.12B 1.11B 1.1B 1.09B 984.65M 957.4M 924.58M 928.37M 884.41M
Interest Expense
34.18M 30.96M 31.2M 32.97M 33.92M 36.37M 41.58M 45.86M 48.21M 45.99M 39.86M 33.79M 29.92M 29.22M 29.81M 30.16M 31.14M 33.02M
Selling & Marketing Expenses
613.72M 595.28M 588.51M 580.43M 569.85M 567.72M 566.07M 555.97M 550.29M 540.02M 524.5M 521.03M 515.44M 504.22M 486.74M 474.19M 457.95M 433.1M
Cost & Expenses
2.78B 2.79B 2.77B 2.73B 2.7B 2.61B 2.56B 2.51B 2.47B 2.5B 2.47B 2.47B 2.46B 2.34B 2.28B 2.22B 2.18B 2.06B
Income Tax Expense
242.08M 229.47M 221.96M 226.87M 216.47M 222.4M 216.13M 212M 209.58M 186.99M 180.88M 168.99M 159.51M 169.53M 157.81M 131.18M 105.04M 90.74M
Shares Outstanding (Basic)
80.41M 81.32M 81.85M 82.3M 82.63M 83.1M 83.09M 83.1M 83.09M 82.99M 82.93M 83.25M 83.92M 84.41M 84.83M 85.12M 85.33M 85.53M
Shares Outstanding (Diluted)
80.99M 81.92M 82.54M 83.06M 83.39M 83.96M 83.93M 83.99M 83.98M 83.96M 83.81M 84.11M 84.86M 85.56M 86.14M 86.51M 86.65M 86.92M
EPS (Basic)
12.10 10.90 10.76 10.47 10.19 10.43 10.17 9.91 9.53 8.40 8.12 7.96 7.85 8.65 8.74 8.86 8.51 7.89
EPS (Diluted)
12.01 10.82 10.67 10.37 10.10 10.33 10.07 9.80 9.42 8.31 8.03 7.87 7.75 8.53 8.61 8.73 8.39 7.77
EBITDA
1.4B 1.29B 1.28B 1.26B 1.22B 1.24B 1.22B 1.2B 1.17B 1.05B 1.01B 986.1M 964.93M 1.04B 1.04B 1.02B 966.79M 898.97M
EBIT
1.26B 1.16B 1.14B 1.13B 1.1B 1.13B 1.1B 1.08B 1.05B 932.16M 899.83M 872.43M 853.33M 933.27M 932.46M 918.37M 864.35M 798.32M
Depreciation & Amortization
137.67M 134.09M 129.94M 125.97M 120.82M 116.48M 114.91M 113.89M 113.45M 113.72M 111.9M 110.88M 108.8M 106.05M 104.6M 101.46M 99.65M 97.85M